Table of Contents Author Guidelines Submit a Manuscript
Journal of Transplantation
Volume 2012, Article ID 107180, 16 pages
http://dx.doi.org/10.1155/2012/107180
Clinical Study

A Prospective, Multinational Pharmacoepidemiological Study of Clinical Conversion to Sirolimus Immunosuppression after Renal Transplantation

1Division of Nephrology, Hennepin County Medical Center, Minneapolis, MN 55415, USA
2University Medical Center Hamburg-Eppendorf, Hamburg, Germany
3Instituto de Nefrología, Buenos Aires, Argentina
4Fundación Favaloro, Buenos Aires, Argentina
5The Queen Elizabeth Hospital, Adelaide, SA, Australia
6Renal Transplant Unit, Hospital Clinic University of Barcelona, Barcelona, Spain
7Indiana University School of Medicine, Indianapolis, IN, USA
8University of British Columbia and Syreon Corporation, Vancouver, BC, Canada

Received 28 December 2011; Accepted 3 May 2012

Academic Editor: Andreas Zuckermann

Copyright © 2012 Bertram L. Kasiske et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Bertram L. Kasiske, Bjorn Nashan, Maria Del Carmen Rial, et al., “A Prospective, Multinational Pharmacoepidemiological Study of Clinical Conversion to Sirolimus Immunosuppression after Renal Transplantation,” Journal of Transplantation, vol. 2012, Article ID 107180, 16 pages, 2012. https://doi.org/10.1155/2012/107180.